Claudin‑1 expression in cervical cancer

  • Authors:
    • Friederike Hoellen
    • Annika Waldmann
    • Constanze Banz‑Jansen
    • Uwe Holtrich
    • Thomas Karn
    • Martina Oberländer
    • Jens K. Habermann
    • Mareike Hörmann
    • Frank Köster
    • Julika Ribbat‑Idel
    • Marc Thill
    • Achim Rody
    • Ahmed El‑Balat
    • Lars Hanker
  • View Affiliations

  • Published online on: August 25, 2017     https://doi.org/10.3892/mco.2017.1391
  • Pages: 880-884
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Claudin‑1 is a tight junction protein that has been demonstrated to be involved in tumorigenesis and tumor progression in various types of solid tumors. In the present study, the protein expression of claudin‑1 in squamous cervical cancer tissues obtained from 106 patients was analyzed by immunohistochemistry. In addition, the grade of claudin‑1 expression was analyzed for associations with certain clinicopathological parameters. A significant overexpression of claudin‑1 was detected in the tumor cells, when compared with that in the peritumoral stroma. There was no significant association between claudin‑1 expression and FIGO stage, tumor size, grading or the appearance of distant metastases. Cervical cancer patients scoring positive for claudin‑1 protein expression tended to exhibit more lymph node metastasis (28.3%), compared with claudin‑1‑negative patients (7.1%). Regarding overall survival, the results of the present study suggest a better prognosis for claudin‑1‑negative patients. In order to elucidate whether claudin‑1 overexpression has a significant prognostic impact on squamous cervical cancer, further studies are required.
View Figures
View References

Related Articles

Journal Cover

November-2017
Volume 7 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hoellen F, Waldmann A, Banz‑Jansen C, Holtrich U, Karn T, Oberländer M, Habermann JK, Hörmann M, Köster F, Ribbat‑Idel J, Ribbat‑Idel J, et al: Claudin‑1 expression in cervical cancer. Mol Clin Oncol 7: 880-884, 2017
APA
Hoellen, F., Waldmann, A., Banz‑Jansen, C., Holtrich, U., Karn, T., Oberländer, M. ... Hanker, L. (2017). Claudin‑1 expression in cervical cancer. Molecular and Clinical Oncology, 7, 880-884. https://doi.org/10.3892/mco.2017.1391
MLA
Hoellen, F., Waldmann, A., Banz‑Jansen, C., Holtrich, U., Karn, T., Oberländer, M., Habermann, J. K., Hörmann, M., Köster, F., Ribbat‑Idel, J., Thill, M., Rody, A., El‑Balat, A., Hanker, L."Claudin‑1 expression in cervical cancer". Molecular and Clinical Oncology 7.5 (2017): 880-884.
Chicago
Hoellen, F., Waldmann, A., Banz‑Jansen, C., Holtrich, U., Karn, T., Oberländer, M., Habermann, J. K., Hörmann, M., Köster, F., Ribbat‑Idel, J., Thill, M., Rody, A., El‑Balat, A., Hanker, L."Claudin‑1 expression in cervical cancer". Molecular and Clinical Oncology 7, no. 5 (2017): 880-884. https://doi.org/10.3892/mco.2017.1391